Biopharma industry representatives are taking issue with some of the FDA’s more political proposals in the next round of user fee agreements, particularly ones that

Wave Life Sciences has said new clinical trial results with its non-incretin therapy for weight loss are positive – but investors don’t seem to agree.

Milan-based Recordati confirmed Thursday that it has received a buyout offer north of $12 billion. The company said in a press release that private equity

UCB has selected Gwinnett County, GA, as the location for its new biologics factory. The 460,000-square-foot facility is expected to cost $2 billion and will

There’s a reason lots of companies are working on GLP-1-based drugs for obesity: The other stuff tends not to work. The latest biotech to learn